Skip to main content
NIH funding notice RFA-CA-15-022

Proteogenomic Translational Research for Clinical Proteomic Tumor Analysis Consortium (U01)

Closed on May 11, 2016.

Posted
November 2, 2015
Close date
May 11, 2016
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
3
3 new
Median first-year cost
$1,452,478
$4,334,659 in all
Institutions
3
3 contact PIs
Patents
1
from 1 funded project

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. BATTELLE PACIFIC NORTHWEST LABORATORIES1
  2. BAYLOR COLLEGE OF MEDICINE1
  3. FRED HUTCHINSON CANCER RESEARCH CENTER1

Most frequent study sections

  1. Special Emphasis Panel (ZCA1 TCRB-Q (J1))3
3 awards under RFA-CA-15-022 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2017Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit1U01CA214114-01Birrer, MichaelPaulovich, Amanda GFRED HUTCHINSON CANCER RESEARCH CENTER, WAFirst-year cost $1,507,572Study section ZCA1
FY2017MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS1U01CA214125-01Carr, Steven AEllis, Matthew JBAYLOR COLLEGE OF MEDICINE, TXFirst-year cost $1,452,478Study section ZCA1
FY2017Proteogenomic Translational Research Center for Clinical Proteomic1U01CA214116-01Druker, Brian JRodland, Karin DBATTELLE PACIFIC NORTHWEST LABORATORIES, WAFirst-year cost $1,374,609Study section ZCA1
Newest fiscal year first, then first-year cost.

Patents from its funded projects

1 patent names 1 of the 3 funded projects.

  1. US 12,394,502 (opens the patent at USPTO, a PDF, in a new tab)METHOD FOR PREDICTING HLA-BINDING PEPTIDES USING PROTEIN STRUCTURAL FEATURESGranted August 19, 2025 to The General Hospital Corporation, Dana-Farber Cancer Institute, Inc. and The Broad Institute, Inc.U01CA214125 · BAYLOR COLLEGE OF MEDICINE, TX

Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.

Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-15-0.3.4. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.